Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trialSabine C A Meijvis, Douwe H. Biesma, Willem Jan W. Bos et al.|The Lancet|2011Cited by 372
Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysisSimone M.C. Spoorenberg, E.M.W. van de Garde, Willem Jan W. Bos et al.|BMC Infectious Diseases|2014Cited by 58
Chlamydia psittaci: a relevant cause of community-acquired pneumonia in two Dutch hospitals.Spoorenberg Sm, B M de Jongh, Willem Jan W. Bos et al.|PubMed|2016Cited by 38
Biomarkers define the clinical response to dexamethasone in community-acquired pneumoniaHilde H.F. Remmelts, Douwe H. Biesma, Sabine C A Meijvis et al.|Journal of Infection|2012Cited by 34
Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumoniaSimone M.C. Spoorenberg, Ewoudt van de Garde, Rik Heijligenberg et al.|European Respiratory Journal|2014Cited by 24